Company / Operating Cash Flow per Share
Yubo International Biotech Ltd Operating Cash Flow per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.01
FY2025
5-year range
-$0.11 / $0.09
FY2021-FY2025
Trend
+93.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.09 to $-0.01 over the past 5 years.
Based on SEC 10-K filings.
-0.01 in FY2025.
Declined from $0.09 to $-0.01 over the past 5 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 93.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.01 | +93.7% |
| FY2024 | -$0.11 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2020 | $0.09 | +416.0% |
| FY2019 | -$0.03 | +41.8% |
| FY2018 | -$0.05 | +0.0% |
| FY2017 | -$0.05 | +0.0% |
| FY2016 | -$0.05 | +1.8% |
| FY2015 | -$0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026